大剂量地塞米松联合重组人血小板生成素治疗48例成人初治重症原发免疫性血小板减少症的有效性及安全性

OBJECTIVE: To evaluate the efficacy and safety of high dose dexamethasone combined with recombinant human thrombopoietin (rhTPO) in adults with severe newly diagnosed immune thrombocytopenia (ITP). METHODS: Forty-eight adult patients with severe ITP were randomized into two groups, experimental grou...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348189/
https://www.ncbi.nlm.nih.gov/pubmed/27333620
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348189/
https://www.ncbi.nlm.nih.gov/pubmed/27333620
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.02.010

Ejemplares similares